News Releases

Date	Title	Document
Date Dec 07, 2017	Title OncoCyte Presents Positive Data from its Liquid Biopsy Breast Cancer Diagnostic Test at the San Antonio Breast Cancer Symposium	Document PDF
Date Nov 15, 2017	Title Seasoned Financial Executive Joins OncoCyte as Chief Financial Officer	Document PDF
Date Nov 14, 2017	Title OncoCyte Reports Third Quarter 2017 Financial Results	Document PDF
Date Nov 06, 2017	Title OncoCyte to Report Third Quarter 2017 Financial Results on November 14, 2017	Document PDF
Date Sep 27, 2017	Title OncoCyte Announces Successful Completion of CLIA Lab Validation Study of its DetermaVu™ Lung Cancer Diagnostic Test; Clinical Validation Study Initiated	Document PDF
Date Sep 18, 2017	Title OncoCyte Reports Positive Analytical Validation Study Results of DetermaVu™ Lung Cancer Diagnostic Test	Document PDF
Date Sep 11, 2017	Title OncoCyte to Present Data from its Liquid Biopsy Breast Cancer Diagnostic Test at the San Antonio Breast Cancer Symposium	Document PDF
Date Sep 07, 2017	Title OncoCyte Receives CLIA Certification for its Cancer Diagnostics Laboratory	Document PDF
Date Sep 05, 2017	Title Seasoned Diagnostics Sales Executive Joins OncoCyte to Drive Commercialization and Future Sales Initiatives of DetermaVu™, the Company’s Novel Liquid Biopsy Lung Cancer Diagnostic	Document PDF
Date Aug 14, 2017	Title OncoCyte Confirms Launch Plans for Lung Cancer Diagnostic Test; Reports Progress Toward CLIA Lab Licensing and Second Quarter 2017 Financial Results	Document PDF